首页> 中文期刊>中国医药导报 >开放式创新与我国生物医药产业的创新路径

开放式创新与我国生物医药产业的创新路径

     

摘要

Innovation ability is the most important content of the core ability of bio-medical industry. Focused on the main factors which hamper the ability of innovation of China's bio-medical industry, based on the research of the open innovation mode and concerned the possibility of introduce the open innovation into China's bio-medical industry, the impact on the bio-medical industry also be discussed, through which offered a path choice to sustainably improve the ability of industrial innovation of Chinese bio-medical industry from four inspects: make open innovation strategy of bio-medical industry,participate global innovation alliance, strengthen multi-level innovation subject and construct multi-dimension support of open innovation.%创新能力是生物医药产业核心竞争能力的重要内容.文章探讨了阻碍我国生物医药产业创新能力提升的主要因素,在研究开放式创新模式的基础上,考虑将开放式创新纳入我国生物医药产业创新的可能,并从四个方面提出了开放式创新环境下我国生物医药企业持续提升创新能力的创新路径:制定开放式创新战略,参与全球技术创新联盟,强化多层次的创新主体和构筑产业开放式创新的多向支撑.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号